Soraku-gun, Japan

Mihoko Era

This inventor holds 3 USPTO granted patents. Top assignees: Unitika Ltd., Iatron Laboratories Inc.. Active years: 1992-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mihoko Era. Retrieved from https://idiyas.com/inventor/mihoko-era

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Kyoto, JP (1992)
  • Soraku-gun, JP (1998 - 1999)

Company Filing History:


Years Active: 1992-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mihoko Era: Innovator in Creatine Kinase Measurement

Introduction

Mihoko Era is a notable inventor based in Soraku-gun, Japan. He has made significant contributions to the field of biochemistry, particularly in the measurement of creatine kinase activity. With a total of 3 patents to his name, his work has implications for both clinical diagnostics and research.

Latest Patents

One of Mihoko Era's latest patents focuses on a reagent for measuring creatine kinase (CK) activity. This invention provides a method for measuring the CK isoform, utilizing an antibody that inhibits the CK-M.sub.T subunit while not affecting the CK-M.sub.S subunit. The method involves determining the inhibition of CK in body fluids using this specific reagent. This innovative approach enhances the accuracy of CK activity measurements, which is crucial for various medical applications.

Career Highlights

Mihoko Era has worked with prominent companies in the industry, including Unitika Ltd. and Iatron Laboratories Inc. His experience in these organizations has contributed to his expertise in biochemistry and patent development.

Collaborations

Mihoko has collaborated with notable coworkers such as Tadao Suzuki and Tomoko Kamei, who have also contributed to advancements in the field.

Conclusion

Mihoko Era's contributions to the measurement of creatine kinase activity demonstrate his innovative spirit and dedication to improving diagnostic methods. His patents reflect a commitment to advancing biochemistry and enhancing clinical practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…